tiprankstipranks

Michael Aaron Kelly Insider Profile

4 Followers
Michael Aaron Kelly, Director at Hookipa Pharma, holds 65.59K shares in DMC Global (Ticker: BOOM), holds 0.00 shares in Amicus (Ticker: FOLD), holds 49.01K shares in NeoGenomics (Ticker: NEO).
tipranks
Michael Aaron Kelly

Michael Aaron Kelly
Hookipa Pharma (HOOK)
Director

Not Ranked
Michael Aaron Kelly has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$876K
51.87%
46.93%
0.78%
0.42%
0.00% Others
A breakdown of Michael Aaron Kelly's holdings

Insider Roles

DMC Global
(BOOM)
Director
NeoGenomics
(NEO)
Director
Hookipa Pharma
(HOOK)
Director
Aprea Therapeutics
(APRE)
Director
+1 other positions
Roles that Michael Aaron Kelly holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Michael Aaron Kelly

Michael Aaron Kelly's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Hookipa Pharma
Oct 23, 2020
Director
Uninformative Buy
$6.85K
DMC Global
May 14, 2026
Director
Uninformative Buy
$454.54K
NeoGenomics
Jun 03, 2025
Director
Uninformative Buy
89.21K
$411.19K
Aprea Therapeutics
Jul 01, 2021
Director
Uninformative Buy
$3.69K
FOLD
Amicus
Apr 27, 2026
Uninformative Sell
1.05M
$0.00
Prime Medicine, Inc.
Director
List of latest transactions for each holding click on a transaction to see Michael Aaron Kelly's performance on stock

Michael Aaron Kelly insider profile FAQ

What is the percentage of profitable transactions made by Michael Aaron Kelly?
The percentage of profitable transactions made by Michael Aaron Kelly is ―.
    What is the average return per transaction made by Michael Aaron Kelly?
    The average return per transaction made by Michael Aaron Kelly is ―.
      What stocks does Michael Aaron Kelly hold?
      Michael Aaron Kelly holds: HOOK, BOOM, NEO, APRE, FOLD, PRME stocks.
        What was Michael Aaron Kelly’s latest transaction?
        Michael Aaron Kelly latest transaction was an Uninformative Buy of ―.
          What was Michael Aaron Kelly's most profitable transaction?
          Michael Aaron Kelly’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Michael Aaron Kelly's role in Hookipa Pharma?
            Michael Aaron Kelly's role in Hookipa Pharma is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.